Why is US facing shortage of FDA approved drug Adderall?

Why is US facing shortage of FDA approved drug Adderall?
ET Spotlight Special
Rate Story
Share
Font Size
Save
Comment
Synopsis

Adderall, used to treat attention deficit hyperactivity disorder (ADHD), is in short supply in the United States. Since the Covid-19 pandemic, there has been an increasing demand for Adderall. The unfulfilled demand for the drug has existed since August, and pharmacies find it challenging to stock it.

Agencies
The US currently faces a shortage of Adderall that is used to treat attention deficit hyperactivity disorder (ADHD). There has been an increasing demand for the drug since the Covid-19 pandemic, and pharmacies are finding it challenging to stock the product.

Adderall is a US Food Drug and Drug Administration (FDA) approved drug which consists of a combination of dextroamphetamine and amphetamine. It is also used to treat narcolepsy, which causes daytime sleepiness.


Correlation between Attention Disorder and Anxiety Disorder?

Autoplay
1 of 10

Correlation between Attention Disorder and Anxiety Disorder?



ADHD is one of the most commonly found neurodevelopmental disorders in children. Children suffering from ADHD struggle with being attentive and controlling their impulsive behaviour and can be highly active.

ADHD can also continue to adulthood and cause difficulty maintaining relationships or focusing on work. Adderall, as a stimulant, can improve concentration levels and control hyperactivity by increasing dopamine and norepinephrine levels in the brain.

It is declared a schedule II drug in the US, meaning it can also be used for drug abuse. Manufacturing delays and labour shortages cause a shortage in supply.

FAQs


What is Adderall?
Adderall is a stimulant which consists of dextroamphetamine and amphetamine. It is used to treat ADHD.

What is narcolepsy?
Narcolepsy is a sleep condition where a person experiences daytime sleepiness.

Why is there a short supply of Adderall in the US?
Due to labour shortages and manufacturing delays, the US is facing a short supply of Adderall.
Disclaimer Statement: This content is authored by an external agency. The views expressed here are that of the respective authors/ entities and do not represent the views of Economic Times (ET). ET does not guarantee, vouch for or endorse any of its contents nor is responsible for them in any manner whatsoever. Please take all steps necessary to ascertain that any information and content provided is correct, updated, and verified. ET hereby disclaims any and all warranties, express or implied, relating to the report and any content therein.

Read More News on

(Catch all the Business News, Breaking News Events and Latest News Updates on The Economic Times.)

Download The Economic Times News App to get Daily Market Updates & Live Business News.

...more

ETPrime stories of the day

8 mins read
7 mins read
6 mins read